Clinical characteristics and outcomes of children with stage 3-5 chronic kidney disease

被引:58
|
作者
Tran Thi Mong Hiep [1 ]
Ismaili, Khalid [2 ]
Collart, Frederic [3 ]
Van Damme-Lombaerts, Rita [4 ]
Godefroid, Nathalie [5 ]
Ghuysen, Marie-Sophie [6 ,7 ]
Van Hoeck, Koen [8 ]
Raes, Ann [9 ]
Janssen, Francoise [2 ]
Robert, Annie [10 ]
机构
[1] Univ Pham Ngoc Thach, Dept Pediat, Nhi Dong Hosp Grall 2, Ho Chi Minh City, Vietnam
[2] Univ Libre Bruxelles, Dept Pediat Nephrol, Hop Univ Enfants Reine Fabiola, Brussels, Belgium
[3] Free Univ Brussels, Hop Univ Brugmann, Dept Nephrol, B-1020 Brussels, Belgium
[4] UZ Gasthuiberg, Dept Pediat Nephrol & Organ Transplantat, Leuven, Belgium
[5] Catholic Univ Louvain, Dept Nephrol, B-1200 Brussels, Belgium
[6] Ctr Hosp Chretien, Dept Pediat Nephrol, Liege, Belgium
[7] Ctr Hosp Univ Liege, Liege, Belgium
[8] Univ Ziekenhuis Antwerpen, Dept Pediat Nephrol, Edegem, Belgium
[9] Univ Ziekenhuis Gent, Dept Pediat Nephrol, Ghent, Belgium
[10] Catholic Univ Louvain, Dept Epidemiol & Biostat, B-1200 Brussels, Belgium
关键词
End stage renal failure; Mortality; Primary renal disease; Renal replacement therapy; CHRONIC-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; EPIDEMIOLOGY; GUIDELINES; INFANTS;
D O I
10.1007/s00467-009-1424-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aim of this study was to report on the clinical characteristics and outcomes of Belgian children with chronic kidney disease (CKD). Between 2001 and 2005, we followed 143 new successive patients younger than 20 years of age with a glomerular filtration rate of < 60 ml/min/1.73 m(2) prospectively in a Belgian department of pediatric nephrology. The incidence of diagnosed CKD was 11.9 per million child population (pmcp), and the incidence of renal replacement therapy was 6.2 pmcp. There were 67% patients in CKD stage 3, 19% in CKD stage 4 and 14% in CKD stage 5. Patients with congenital anomalies of the kidney and urinary tract (CAKUTs), hereditary diseases and glomerular diseases were diagnosed at a median age of 1, 2 and 10 years, respectively. CAKUTs were the main causes of CKD, accounting for 59% of all cases. After 3, 4 and 5 years of follow-up, 27, 31 and 38% of patients treated conservatively, respectively, reached end-stage renal failure (ESRF). The progression rate to ESRF was eightfold higher in patients with CKD stage 4 than in those with CKD stage 3. Among our patient group, hereditary diseases progressed more rapidly to ESRF than CAKUTs. Transplantation was performed preemptively in 22% of these children. Infections and cardiovascular diseases were the main causes of death.
引用
收藏
页码:935 / 940
页数:6
相关论文
共 50 条
  • [31] Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5)
    Zurowska, Aleksandra M.
    Fischbach, Michel
    Watson, Alan R.
    Edefonti, Alberto
    Stefanidis, Constantinos J.
    PEDIATRIC NEPHROLOGY, 2013, 28 (09) : 1739 - 1748
  • [32] Serum potassium abnormalities in chronic kidney disease: prevalence, patient characteristics and clinical outcomes
    Brookes, Elizabeth M.
    Snider, Jonathan
    Hart, Graeme K.
    Robbins, Raymond
    Power, David A.
    INTERNAL MEDICINE JOURNAL, 2021, 51 (11) : 1906 - 1918
  • [33] NT-proBNP in the Prognosis of Death or Need for Renal Replacement Therapy in Patients with Stage 3-5 Chronic Kidney Disease
    Gromadzinski, Leszek
    Januszko-Giergielewicz, Beata
    Czarnacka, Kamila
    Pruszczyk, Piotr
    CARDIORENAL MEDICINE, 2019, 9 (02) : 125 - 134
  • [34] Influence of dietary protein intake on body composition in chronic kidney disease patients in stages 3-5: A cross-sectional study
    Barril, Guillermina
    Nogueira, Angel
    Ruperto Lopez, Mar
    Castro, Yone
    Antonio Sanchez-Tomero, Jose
    NEFROLOGIA, 2018, 38 (06): : 647 - 654
  • [35] Outcomes of stage 1-5 chronic kidney disease in Mainland China
    Lai, Xuan
    Zhang, Ai-Hua
    Chen, Shao-Yan
    He, Lian
    Su, Chun-Yan
    Fan, Min-Hua
    Wang, Tao
    RENAL FAILURE, 2014, 36 (04) : 520 - 525
  • [36] Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5
    Rianthavorn, Pornpimol
    Boonyapapong, Pantipa
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1261 - 1266
  • [37] ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials
    Zhang, Yaru
    He, Dandan
    Zhang, Wei
    Xing, Yue
    Guo, Yipeng
    Wang, Fuzhen
    Jia, Junya
    Yan, Tiekun
    Liu, Youxia
    Lin, Shan
    DRUGS, 2020, 80 (08) : 797 - 811
  • [38] Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes
    Lam, Ngan N.
    Tonelli, Marcello
    Lentine, Krista L.
    Hemmelgarn, Brenda
    Ye, Feng
    Wen, Kevin
    Klarenbach, Scott
    KIDNEY INTERNATIONAL, 2017, 92 (02) : 470 - 478
  • [39] Do patients with Stage 3-5 chronic kidney disease benefit from ischaemia-sparing techniques during partial nephrectomy?
    Beksac, Alp Tuna
    Okhawere, Kennedy E.
    Rosen, Daniel C.
    Elbakry, Amr
    Dayal, Bheesham D.
    Daza, Jorge
    Sfakianos, John P.
    Ronney, Abaza
    Eun, Daniel D.
    Bhandari, Akshay
    Hemal, Ashok K.
    Porter, James
    Stifelman, Michael D.
    Badani, Ketan K.
    BJU INTERNATIONAL, 2020, 125 (03) : 442 - 448
  • [40] Five-Year Incidence of Chronic Kidney Disease (Stage 3-5) and Associated Risk Factors in a Spanish Cohort: The MADIABETES Study
    Salinero-Fort, Miguel A.
    San Andres-Rebollo, Francisco J.
    de Burgos-Lunar, Carmen
    Gomez-Campelo, Paloma
    Chico-Moraleja, Rosa M.
    Lopez de Andres, Ana
    Jimenez-Garcia, Rodrigo
    PLOS ONE, 2015, 10 (04):